Palatin Technologies Inc.
PTN
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.04M
Close$
$4.46
12.7% downside
Current Fair Value
12.7% downsideOvervalued by 12.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $20.04 Million |
|---|---|
| Enterprise Value | $12.77 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.96 |
| Beta | -0.07 |
| Outstanding Shares | 3,921,182 |
Return
| Return on Equity | -125.30% |
|---|---|
| Return on Assets | -98.29% |
| Return on Invested Capital | -128.57% |
Valuation & Multiples
| P/E Ratio | -0.97 |
|---|---|
| PEG | -1.02 |
| Price to Sales | 1.7 |
| Price to Book Ratio | 5.11 |
| Enterprise Value to Revenue | 0.97 |
| Enterprise Value to EBIT | -1.47 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 28, 2026
EPS Estimate
$-1.20
Average shareholder expectationRevenue Estimate
$1.50 M
Average shareholder expectationNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
$-0.42
Average shareholder expectationRevenue Estimate
$2.51 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 70.48%▼ 8.88% |
|---|---|
| Total Invested | $7.39M▼ 44.99% |
| Investors Holding | 250% |
ESG Score
No data
About Palatin Technologies Inc.
25 employees
CEO: Carl Spana Palatin Technologies, Inc., established in Cranbury, New Jersey, in 1986, is a biopharmaceutical company focused on developing specialized, receptor-targeting therapeutics for various medical conditions within the United States. The firm...